INTERNATIONAL PATENT: ALFASIGMA S.P.A. FILES APPLICATION FOR "BIOMARKERS FOR DETERMINING TREATMENT OF ULCERATIVE COLITIS WITH FILGOTINIB"

GENEVA, Feb. 9 -- ALFASIGMA S.P.A. (5, Via Ragazzi del '9940133 Bologna) filed a patent application (PCT/EP2025/072063) for "BIOMARKERS FOR DETERMINING TREATMENT OF ULCERATIVE COLITIS WITH FILGOTINIB" on Jul 31, 2025. With publication no. WO/2026/027676, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MALKOV, Vladislav A. (814 Balboa Lane, Foster City,Foster City, California 94404), LIANG, Yan (c/o Gilead Sciences, lnc.333 Lakeside Drive,Foster City, California 94404), WENDT, Emily (c/o Gilead Sciences, lnc.333 Lakeside D...